Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Cash from Investing Activities: 2012-2025

Historic Cash from Investing Activities for CorMedix (CRMD) over the last 9 years, with Sep 2025 value amounting to -$291.3 million.

  • CorMedix's Cash from Investing Activities fell 4708.50% to -$291.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$312.0 million, marking a year-over-year decrease of 4656.48%. This contributed to the annual value of $21.2 million for FY2024, which is 224.44% up from last year.
  • According to the latest figures from Q3 2025, CorMedix's Cash from Investing Activities is -$291.3 million, which was down 1,341.34% from -$20.2 million recorded in Q2 2025.
  • CorMedix's 5-year Cash from Investing Activities high stood at $8.9 million for Q1 2024, and its period low was -$291.3 million during Q3 2025.
  • In the last 3 years, CorMedix's Cash from Investing Activities had a median value of -$249,490 in 2024 and averaged -$38.1 million.
  • As far as peak fluctuations go, CorMedix's Cash from Investing Activities surged by 385.41% in 2022, and later crashed by 4,708.50% in 2025.
  • CorMedix's Cash from Investing Activities (Quarterly) stood at -$7.1 million in 2021, then spiked by 99.97% to -$1,861 in 2022, then slumped by 250.72% to -$14.7 million in 2023, then skyrocketed by 160.90% to -$304,161 in 2024, then tumbled by 4,708.50% to -$291.3 million in 2025.
  • Its Cash from Investing Activities stands at -$291.3 million for Q3 2025, versus -$20.2 million for Q2 2025 and -$194,820 for Q1 2025.